Quantum Genomics Société Anonyme (EPA:ALQGC)
0.0721
0.00 (0.00%)
Oct 24, 2024, 5:35 PM CET
EPA:ALQGC Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 0.3 | 3.55 | 10.4 | 13.55 | 27.15 |
Short-Term Investments | - | - | - | 0.26 | 0.29 |
Cash & Short-Term Investments | 0.3 | 3.55 | 10.4 | 13.81 | 27.44 |
Cash Growth | -91.51% | -65.89% | -24.68% | -49.67% | 141.36% |
Accounts Receivable | - | - | - | 0.7 | 0.74 |
Other Receivables | 0.03 | 0.12 | 12.9 | 3.19 | 2.9 |
Receivables | 0.03 | 0.12 | 12.9 | 3.88 | 3.64 |
Prepaid Expenses | 0.02 | 0.02 | 0.09 | - | - |
Other Current Assets | 0 | 0 | 0 | 2.54 | 0.75 |
Total Current Assets | 0.35 | 3.69 | 23.39 | 20.23 | 31.83 |
Property, Plant & Equipment | 0 | 0.01 | 0.02 | 0.44 | 0.18 |
Long-Term Investments | - | 0.04 | 0.21 | - | - |
Other Intangible Assets | - | - | - | 0.54 | 0.76 |
Other Long-Term Assets | 0 | 0.01 | 0.03 | 0.03 | 0.03 |
Total Assets | 0.35 | 3.75 | 23.66 | 21.24 | 32.8 |
Accounts Payable | 0.15 | 0.27 | 16.01 | 6.75 | 5.92 |
Accrued Expenses | 0.03 | 0.32 | - | 0.65 | 0.71 |
Short-Term Debt | 0 | - | - | - | - |
Current Portion of Long-Term Debt | 0.78 | - | - | 0.16 | 0.25 |
Current Portion of Leases | - | - | - | 0.13 | 0.13 |
Current Income Taxes Payable | - | - | 0.96 | 0.06 | 0.06 |
Current Unearned Revenue | - | - | - | 0.13 | 0.2 |
Other Current Liabilities | - | 0.01 | 0.01 | - | 0.01 |
Total Current Liabilities | 0.95 | 0.59 | 16.97 | 7.87 | 7.27 |
Long-Term Debt | 1.86 | 2.72 | 3.03 | 2.88 | 0.47 |
Long-Term Leases | - | - | - | 0.29 | 0.03 |
Pension & Post-Retirement Benefits | - | - | - | 0.44 | 0.38 |
Other Long-Term Liabilities | 0 | 0 | 0.04 | 0.1 | - |
Total Liabilities | 2.81 | 3.31 | 20.05 | 11.58 | 8.15 |
Common Stock | 2.79 | 13.94 | 13.94 | 10.97 | 10.68 |
Additional Paid-In Capital | 4.61 | 14.61 | 14.61 | 17.01 | 27.99 |
Retained Earnings | -9.85 | -28.11 | -24.93 | - | - |
Comprehensive Income & Other | 0 | - | - | -18.31 | -14.02 |
Shareholders' Equity | -2.46 | 0.44 | 3.61 | 9.67 | 24.65 |
Total Liabilities & Equity | 0.35 | 3.75 | 23.66 | 21.24 | 32.8 |
Total Debt | 2.64 | 2.72 | 3.03 | 3.46 | 0.88 |
Net Cash (Debt) | -2.34 | 0.83 | 7.37 | 10.35 | 26.55 |
Net Cash Growth | - | -88.73% | -28.81% | -61.03% | 155.77% |
Net Cash Per Share | -0.03 | 0.02 | 0.21 | 0.38 | 1.30 |
Filing Date Shares Outstanding | 69.71 | 34.85 | 34.85 | 34.62 | 26.89 |
Total Common Shares Outstanding | 69.71 | 34.85 | 34.85 | 27.44 | 26.71 |
Working Capital | -0.6 | 3.09 | 6.42 | 12.37 | 24.56 |
Book Value Per Share | -0.04 | 0.01 | 0.10 | 0.35 | 0.92 |
Tangible Book Value | -2.46 | 0.44 | 3.61 | 9.13 | 23.89 |
Tangible Book Value Per Share | -0.04 | 0.01 | 0.10 | 0.33 | 0.89 |
Machinery | - | - | - | 0.07 | 0.06 |